Skip to Main Navigation

Republic of Congo COVID-19 Emergency Response Project

Abstract*

This COVID-19 Emergency Response Project will support the implementation of the Government of Congo's Integrated COVID-19 Preparedness and Response Plan which was developed under the leadership of the Ministry of Health with support from the donor community. The Plan puts in place measures to control the spread of COVID-19 and mitigate its impact. These measures are around key strategic response areas as guided by International Health Regulations...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prevent, detect, and respond to the threat posed by COVID-19 and strengthen the national system for public health preparedness in the Republic of Congo.

Key Details

Project Details

  • P173851

  • Closed

  • Djibrilla Karamoko

  • Republic of Congo

  • Congo, Republic of

  • April 9, 2020

  • (as of board presentation)

    April 20, 2020

  • May 26, 2020

  • US$ 26.31 million

  • Ministry of Health and Population

  • Western and Central Africa

  • 2020

  • US$ 26.31 million

  • N/A

  • Substantial

  • June 30, 2024

  • No

  • BANK APPROVED

  • June 28, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Health Emergency Preparedness and Response Multi-Donor Trust 3.00
IDA Credit 23.31

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 23.31
IBRD + IDA Commitment 23.31
Lending Instrument
Grant Amount 3.00
Total Project Cost** 26.31

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
May 26, 2023 IDA-66340 Int Charges 39,873.18
Apr 5, 2024 IDA-71940 Loan Disb 1,000,869.10
Apr 22, 2024 IDA-69530 Loan Disb 1,018,826.56
May 13, 2024 IDA-66340 Loan Disb -1,820,739.20
Nov 20, 2023 IDA-66340 Int Charges 40,937.13
Nov 20, 2023 IDA-66340 Int Charges 40,937.13
Nov 20, 2023 IDA-66340 Int Charges 24,562.27
Nov 20, 2023 IDA-69530 Int Charges 15,997.50
Nov 20, 2023 IDA-69530 Int Charges 15,997.50
Nov 20, 2023 IDA-69530 Int Charges 3,199.50
Apr 20, 2020 IDA-66340 Loan Commitment 11,310,000.00
Jun 29, 2022 IDA-71940 Loan Commitment 29,670,000.00
Jun 2, 2021 IDA-69530 Loan Commitment 12,000,000.00
Jun 30, 2024 IDA-66340 Loan Cancel 1,990,801.60
Jun 30, 2024 IDA-69530 Loan Cancel 3,869,995.50
Jun 30, 2024 IDA-71940 Loan Cancel 5,924,590.50
Jun 25, 2024 IDA-69530 Loan Disb 351,349.97
May 20, 2024 IDA-69530 Int Charges 3,336.65
May 20, 2024 IDA-69530 Int Charges 19,673.13
May 20, 2024 IDA-69530 Int Charges 19,673.13
May 20, 2024 IDA-66340 Int Charges 41,254.43
May 20, 2024 IDA-66340 Int Charges 41,254.43
May 20, 2024 IDA-66340 Int Charges 24,752.64
May 7, 2024 IDA-71940 Loan Disb 998,059.70
May 7, 2024 IDA-71940 Loan Disb 1,016,068.94
Feb 9, 2024 IDA-69530 Loan Disb 1,611,844.00
Feb 9, 2024 IDA-66340 Loan Disb 253,754.42
Aug 31, 2020 IDA-66340 Loan Disb 2,286,601.50
Aug 6, 2020 IDA-66340 Loan Disb 79,587.76
Nov 19, 2020 IDA-66340 Int Charges 10,748.25
Nov 19, 2020 IDA-66340 Int Charges 10,748.25
May 31, 2021 IDA-66340 Int Charges 1,659.31
May 31, 2021 IDA-66340 Int Charges 35,276.77
May 31, 2021 IDA-66340 Int Charges 35,276.77
May 31, 2021 IDA-66340 Int Charges 21,166.07
Dec 23, 2020 IDA-66340 Loan Disb 65,429.09
Nov 19, 2020 IDA-66340 Int Charges 4,837.60
Nov 19, 2020 IDA-66340 Loan Disb 3,094,364.80
Sep 18, 2020 IDA-66340 Loan Disb 574,103.30
Jul 16, 2020 IDA-66340 Loan Disb 2,341,233.80
Oct 14, 2020 IDA-66340 Loan Disb 497,887.62
Dec 8, 2020 IDA-66340 Loan Disb 55,079.96
Dec 8, 2020 IDA-66340 Loan Disb 55,079.95
Nov 17, 2020 IDA-66340 Loan Disb 108,071.64
May 19, 2022 IDA-69530 Int Charges 7,818.09
May 19, 2022 IDA-69530 Int Charges 7,818.09
May 19, 2022 IDA-69530 Int Charges 1,556.25
May 19, 2022 IDA-66340 Int Charges 18,473.88
May 19, 2022 IDA-66340 Int Charges 30,789.79
May 19, 2022 IDA-66340 Int Charges 30,789.79
Nov 26, 2021 IDA-66340 Int Charges 32,983.21
Nov 26, 2021 IDA-66340 Int Charges 32,983.21
Nov 26, 2021 IDA-66340 Int Charges 19,789.94
Nov 15, 2022 IDA-69530 Int Charges 7.29
Nov 15, 2022 IDA-69530 Int Charges 15,249.10
Nov 15, 2022 IDA-69530 Int Charges 15,249.10
Nov 15, 2022 IDA-69530 Int Charges 3,042.53
Nov 15, 2022 IDA-66340 Int Charges 18,270.33
Nov 15, 2022 IDA-66340 Int Charges 30,450.54
Nov 15, 2022 IDA-66340 Int Charges 30,450.54
Nov 23, 2022 IDA-66340 Loan Disb 2,265,629.00
Feb 7, 2022 IDA-69530 Loan Disb 2,238,434.00
Feb 7, 2022 IDA-69530 Loan Disb 87,388.64
Mar 10, 2022 IDA-69530 Loan Disb 715,717.10
Feb 11, 2022 IDA-69530 Loan Disb 1,395,642.90
May 26, 2023 IDA-69530 Int Charges 7.52
May 26, 2023 IDA-69530 Int Charges 15,735.34
May 26, 2023 IDA-69530 Int Charges 15,735.34
May 26, 2023 IDA-69530 Int Charges 3,147.07
Jun 30, 2023 IDA-71940 Loan Cancel 21,134,712.00
May 26, 2023 IDA-66340 Int Charges 23,923.89
May 26, 2023 IDA-66340 Int Charges 39,873.18

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Moderately Satisfactory 2024-06-03
Project Management Moderately Unsatisfactory 2024-06-03
Procurement Moderately Satisfactory 2024-06-03
Financial Management Moderately Unsatisfactory 2024-06-03
Monitoring and Evaluation Moderately Unsatisfactory 2024-06-03
Overall Implementation Progress (IP) Moderately Unsatisfactory 2024-06-03

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue0.0019.0018.00
    DateApril 13, 2020November 30, 2023April 30, 2024
    Comment
  • Country-specific risk communication and community engagement strategy developed and disseminatedValue0.003.003.00
    DateApril 13, 2020November 30, 2023April 30, 2024
    Comment
  • Acute healthcare facilities with isolation capacityValue0.0019.0016.00
    DateApril 20, 2020November 30, 2023April 30, 2024
    Comment
  • Suspected cases of COVID-19 reported and investigated based on national guidelinesValue0.0094.0090.00
    DateApril 13, 2020November 30, 2023April 30, 2024
    Comment
  • Population vaccinated with a COVID-19 vaccineValue0.0011.5930.00
    DateApril 30, 2021November 30, 2023April 30, 2024
    Comment
  • Number of departments with less than 10% vaccinatedValue12.009.000.00
    Date
    Comment
  • Proportion of women among those vaccinatedValue0.0030.000.00
    Date
    Comment
  • Proportion of indigenous women vaccinatedValue0.000.000.00
    Date
    Comment
  • Health centers with adequate WASH facilitiesValue77.0079.00124.00
    DateApril 13, 2020November 30, 2023April 30, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Health staff trained in infection prevention and control per MOH-approved protocolsValue0.00544.001000.00
    DateApril 20, 2020November 30, 2023April 30, 2024
    Comment
  • Communication campaigns about COVID-19 broadcasted to communitiesValue0.009.0020.00
    DateApril 20, 2020November 30, 2023April 30, 2024
    Comment
  • M&E systems established to monitor COVID-19 preparedness and response planValue0.002.001.00
    DateApril 20, 2020November 30, 2023April 29, 2022
    Comment
  • Number of departments with a referral system to care for COVID-19 patientsValue0.0012.004.00
    DateApril 20, 2020November 30, 2023April 30, 2024
    Comment
  • Mobile community health promotion and COVID-19 sensitization campaigns, coupled with mobile vaccinationValue0.000.0024.00
    DateMay 31, 2022November 30, 2023April 30, 2024
    Comment
  • COVID-19 Response M&E reports prepared by the Technical CommitteeValue0.00244.00120.00
    DateApril 20, 2020November 30, 2023April 30, 2024
    Comment
  • Acute healthcare facilities with triage capacityValue0.008.0016.00
    DateApril 20, 2020November 30, 2023April 30, 2024
    Comment
  • Percentage of received grievances addressed through the GRM in a timely mannnerValue0.000.0090.00
    DateSeptember 18, 2020November 30, 2023April 30, 2024
    Comment
  • Multi-sectoral simulation exercises conducted with results incorporated into national COVID-19 preparedness and response plansValue0.001.001.00
    DateApril 20, 2020November 30, 2023April 30, 2024
    Comment
  • Designated laboratories with staff trained to conduct COVID-19 diagnosisValue0.0012.0024.00
    DateApril 20, 2020November 30, 2023April 30, 2024
    Comment
  • Pressure Swing Absorption (PSA) oxygen generating plant installed and functionalValue0.004.002.00
    DateMay 31, 2022April 30, 2024April 30, 2024
    Comment
  • At least one report on waste-disposal activities conducted by health facilities has been published in the last quarterValueNoYesYes
    DateMay 31, 2022November 30, 2023April 30, 2024
    Comment
  • Absorption rate of COVID-19 vaccines acquiredValue0.0032.1080.00
    DateMay 1, 2022November 30, 2023April 30, 2024
    Comment
  • Country has updated preparedness plans (multi-year and annual)ValueNoYesYes
    DateMarch 31, 2022November 30, 2023April 30, 2024
    Comment
  • Country has a comprehensive health sector emergency response coordination mechanism with a functional national emergency operationscentreValueNoYesYes
    DateMarch 31, 2022November 30, 2023April 30, 2024
    Comment